pRM053 His-TEV-Cas9 triNLS 0C Citations (2)

Originally described in: Peptide-mediated delivery of CRISPR enzymes for the efficient editing of primary human lymphocytes.
Foss DV, Muldoon JJ, Nguyen DN, Carr D, Sahu SU, Hunsinger JM, Wyman SK, Krishnappa N, Mendonsa R, Schanzer EV, Shy BR, Vykunta VS, Allain V, Li Z, Marson A, Eyquem J, Wilson RC Nat Biomed Eng. 2023 May;7(5):647-660. doi: 10.1038/s41551-023-01032-2. Epub 2023 Apr 25. PubMed Journal

---

Articles Citing pRM053 His-TEV-Cas9 triNLS 0C

Articles
Peptide-enabled ribonucleoprotein delivery for CRISPR engineering (PERC) in primary human immune cells and hematopoietic stem cells. Sahu SU, Castro M, Muldoon JJ, Asija K, Wyman SK, Krishnappa N, de Onate L, Eyquem J, Nguyen DN, Wilson RC. Nat Protoc. 2025 Mar 3. doi: 10.1038/s41596-025-01154-8. PubMed
Efficient in vivo mammalian neuron editing using peptide-mediated CRISPR enzyme delivery. Manohar BD, Travis M, Munjal V, Baehr CM, Rahnama LMA, Kang MH, Haddad RF, Asija K, Noel EA, Peddireddy N, Chouhan RS, Sharma R, Wyman SK, Krishnappa N, Killebrew DA, Li SH, Snow KJ, Byrne AK, Boosani CS, Otero PA, Bringas J, O'Brien AA, Rocco MT, Zimmerly MP, Gray I, Sran GK, Patel MI, Seidensticker EF, Saville E, Gaitan Y, Schmelzle AL, Subramanyam PNB, Samaranch L, Green JA, Wells KD, Ehrenberg AJ, Murray SA, Clelland CD, Murthy N, Lonser RR, Hadaczek P, Van Laar VS, Bankiewicz KS, Wilson RC. bioRxiv [Preprint]. 2025 Nov 29:2025.11.26.690638. doi: 10.1101/2025.11.26.690638. PubMed

If you have published an article using this material, please email us at to have your article added to this page.